The changing face of medical device vigilance & market surveillance in the EU
This article was originally published in Clinica
Executive Summary
A great deal is changing in terms of vigilance and post-market surveillance at EU member state level, and even globally, to ensure that there is more transparency for all involved in the reporting and analysing of incidents or near-incidents with medical devices. The result is an increasingly watertight system, reports Amanda Maxwell